NEW YORK (GenomeWeb) – Meridian Bioscience today announced an agreement with healthcare alliance Premier to offer Meridian's illumigene molecular tests.

Premier serves more than 3,000 hospitals and 110,000 other healthcare sites. Under the agreement, Premier facilities will offer Meridian's tests for C. difficile, Group A and B Streptococcus, Bordetella pertussis, and Mycoplasma pneumoniae on the illumigene platform, which uses loop-mediated isothermal DNA amplification technology to provide results in less than one hour.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.